Stock Information
Repligen Corp (RGEN)
Ticker Symbol: RGEN
Exchange: NASDAQ
Sector: Life Sciences Tools & Services
Market Cap: $6,529.34 mil
Piotroski score: 5
PE Ratio: 112.8989
EPS (TTM): 0.9084
Revenue (TTM): $13.47 M
Dividend Yield: N/A%
ROE: 2.46%
Latest News
-
3 Small-Cap Stocks We Steer Clear Of
Fri, May 15, 2026 1:08 PM
-
RBC Capital Reinstates Outperform on Repligen, Announces $160 Price Target
Fri, May 15, 2026 10:14 AM
-
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call
Fri, May 15, 2026 9:48 AM
-
Alger Mid Cap 40 ETF Q1 2026 Portfolio Movers
Wed, May 13, 2026 10:50 PM
-
Repligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Tue, May 12, 2026 4:11 PM
-
Transcript : Repligen Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Tue, May 12, 2026 2:05 PM
-
Barclays Maintains an “Overweight Rating” on Repligen Corporation (RGEN)
Tue, May 12, 2026 12:03 AM
Key Financials
Financial data not available
